After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, AURA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Aura Biosciences Inc is $388.87M. A total of 0.13 million shares were traded on the day, compared to an average of 186.30K shares.
In the most recent transaction, Elazzouzi Amy sold 7,722 shares of AURA for 6.70 per share on Aug 18 ’25. After the transaction, the Senior Vice President, Finance now owns 86,558 company shares. In a previous transaction on Aug 18 ’25, AMY F ELAZZOUZI bought 7,722 shares at 6.70 per share.
Among the insiders who bought shares, Johnson David Michael acquired of 20,000 shares on May 16 ’25 at a per-share price of $4.90. This resulted in the Director holding 166,167 shares of AURA after the transaction. In another insider transaction, Gibney Anthony S bought 50,000 shares at $4.90 per share on May 16 ’25. Company shares held by the insider now total 58,452.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, AURA has a high of $12.38 and a low of $4.34.
As of this writing, AURA has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.45 per share and a lower estimate of -$0.49. The company reported an EPS of -$0.42 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. AURA’s latest balance sheet shows that the firm has $149.06M in Cash & Short Term Investments as of fiscal 2021. There were $975.00k in debt and $7.36M in liabilities at the time. Its Book Value Per Share was $2.81, while its Total Shareholder’s Equity was $152.31M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AURA is Buy with a score of 4.75.
